Desensitization Efficacy by Sublingual Immunotherapy of Shrimps Extract in Asthmatic, Rhinitis and Urticaria Allergic Patients

Maged M. Refaat, Mohammed Yousef Attia, Howida Mohamed Saber

1Internal Medicine, Allergy and Immunology Unit, Ain-Shams University Hospital, Cairo, Egypt.
Allergy and Immunology Unit, Ain-Shams University Hospital, Cairo, Egypt.
Clinical Pathology Department, Faculty of Medicine, Ain-Shams University Hospital, Cairo, Egypt.

DOI: 10.4236/fns.2014.517183                

Abstract

RATIONALE: Crustaceans, such as shrimp, crab, crayfish and lobster, play important role in human nutrition; they also can be important causes of severe acute hypersensitivity reactions. For patients diagnosed with a crustacean allergy, strict avoidance is the only proven therapy, highlighting the need for more specific treatment. Our aim was to evaluate the efficacy and tolerance of sublingual shrimp immunotherapy in Egyptian patients allergic to shrimp. METHODS: This study was intended to help in diagnosis of shrimps allergen in 60 allergic patients (subdivided to 3 groups Urticaria (G1), rhinitis (G2) & asthma (G3)) and evaluate the sublingual immunotherapy by employing skin prick test, specific Immunoglobulin E, Total Immunoglobulin E, Immunoglobulin G, Eosinophilis and Peak Expiratory Flow Rate (PEFR), before and after therapy. Inclusion criteria were a history of shrimp allergy and positive skin prick test to crude shrimp extract from two species [Penaeus semisulcatus and Metapenaeus stebbingi] at allergy and clinical immunology unit, in-Shams Hospitals. They underwent immunotherapy with extract of shrimp species and administered sublingually (SLIT). The measurement of all latter investigations for shrimp allergen on the start and 6 months after immunotherapy, as compared to placebo control, were performed. Results: The clinical response and laboratory improvement of the patients was correlated with their decline in the eosinophils (p < 0.001), total Immunoglobulin E (p < 0.001) and specific Immunoglobulin E test (p < 0.001) and with their increased in PEFR (p < 0.001) and Immunoglobulin G (p < 0.001). This study suggests that the most desenstized responsed group was rhinitis group followed by Urticaria group. Also,The more effective season induce allergy in summer (48.3%) followed by springs (28.3%) and genatic predisposition of allergic diseases was highly accepted in patients had a family history (68%). In conclusion, sublingual immunotherapy for shrimp allergy was safe, simple, uncostly, well tolerated and efficacious, gave a good results especially in the treatment of patients with allergic rhinitis.

Keywords

Shrimps, Allergy, Immunotherapy

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Ivor, E.A., Michael, P.J. and Traub, O. (2009) Under Treatment of Allergy: Exploring the Utility of Sublingual Immunotherapy. Otolaryngology—Head and Neck Surgery, 140, 615-621. http://dx.doi.org/10.1016/j.otohns.2009.01.023
[2]	Dworin, M. (1979) Use of the Pulmonary Mointor in the Control of Asthma. The American College of Allergists. 35th Annual Congress, San Francisco, 25-31.
[3]	El-Shami and Aloba (1989) Liquid Phase in Vitro Allergen IgE Assay with Situimmobilization. Advanced Bio Sci., 74, 191-201.
[4]	Nancy, O. (2009) Food Allergy in Children. Minnesota Physician, 13, 16-17.
[5]	Leatherman, B.D., Owen, S., Parker, M., et al. (2007) Sublingual Immunotherapy: Past, Present, Paradigm for the Future? A Review of the Literature. Otolaryngology—Head and Neck Surgery, 136, S1-S20.
[6]	Kelly, K.J. and Brian, K. (2010) Diagnosis and Treatment of Latex Allergy. Inernal Allergy Frontiers: Therapy and Prevention, Pawankar R. Springer Japan.
[7]	Frew, A.J. (2010) Allergen Immunotherapy. Journal of Allergy & Clinical Immunology, 125, S306-S313.
[8]	Jirapongsananuruk, O., Sripramong, C., Pacharn, P., et al. (2008) Speci?c Allergy to Penaeus monodon (Seawater Shrimp) or Macrobrachium rosenbergii (Fresh-Water Shrimp) in Shrimp-Allergic Children. Clinical Experimental Allergy, 38, 1038-1047. http://dx.doi.org/10.1111/j.1365-2222.2008.02979.x
[9]	Lopata, A.L., O’Hehir, R.E. and Lehrer, S.B. (2010) Shellfish Allergy. Clinical & Experimental Allergy, 40.
[10]	Ivor, E.A., Michael, P.J. and Traub, O. (2009) Under Treatment of Allergy: Exploring the Utility of Sublingual Immunotherapy. Otolaryngology—Head and Neck Surgery, 140, 615-621.
[11]	Villalta, D., Tonutti, E., Visentini, D., Bizzaro, N., Roncarolo, D., Amato, S. and Mistrello, G. (2010) Detection of a Novel 20 kDa Shrimp Allergen Showing Cross-Reactivity to House Dust Mites. European Annals of Allergy and Clinical Immunology, 42, 20-24.
[12]	Passalacqua, G. and Canonica, G.W. (2006) Sublingual Immunotherapy. Current Opinion in Allergy & Clinical Immunology, 6, 449-454. http://dx.doi.org/10.1097/01.all.0000246617.41871.40
[13]	Hamilton, R.G. and Adkinson, N.F. (2003) Clinical Laboratory Assessment of IgE-Dependent Hypersensitivity. Journal of Allergy and Clinical Immunology, 111, S687-S701. http://dx.doi.org/10.1067/mai.2003.123
[14]	Douglass, J.A. and O’Hehir, R.E. (2006) Diagnosis, Treatment and Prevention of Allergic Disease: The Basics. Medical Journal of Australia, 185, 228-233.
[15]	Sicherer, S.H. and Sampson, H.A. (2010) Food Allergy. Journal of Allergy & Clinical Immunology, 125, S116-S125.
[16]	Nowak-W?grzyn, A. and Fiocchi, A. (2010) Is Oral Immunotherapy the Cure for Food Allergies? Current Opinion in Allergy and Clinical Immunology, 10, 214-219. http://dx.doi.org/10.1097/ACI.0b013e3283399404
[17]	Asero, R., Mistrello, G., Ariano, R., Colombo, G., Conte, M.E., Crivellaro, M., de Carli, M., Torre, F.D., Emiliani, F., Rizzini, F.L., Longo, R., Macchia, D., Minale, P., Murzilli, F., Nebiolo, F., Quercia, O., Senna, G.E. and Villalta, D. (2012) Shrimp Allergy in Italian Adults: A Multicenter Study Showing a High Prevalence of Sensitivity to Novel High Molecular Weight Allergens. International Archives of Allergy and Immunology, 157, 3-10. http://dx.doi.org/10.1159/000324470
[18]	Bidad, K., Nicknam, M.H. and Farid, R. (2011) A Review of Allergy and Allergen Specific Immunotherapy. The Iranian Journal of Allergy, Asthma and Immunology, 10, 1-9.
[19]	Straumann, A., Conus, S., Grzonka, P., et al. (2010) Anti-Interleukin-5 Antibody Treatment (Mepolizumab) in Active Eosinophilic Oesophagitis: A Randomised, Placebo-Controlled, Double-Blind Trial. Gut, 59, 21-30. http://dx.doi.org/10.1136/gut.2009.178558
[20]	Slavin, R.G. and Reisman, R.E. (2001) Textbook: Expert Guide to Allergy and Immunology. Fulcrum Data Services, Philadelphia. Allergic Skin Diseases, 81-103. Rhinitis, 23-28.